Oncology
From the Journals
Black patients less likely to receive opioids for advanced cancer
Black patients were more likely to undergo urine drug screening despite being less likely to receive any opioids for pain management.
From the Journals
Loneliness risk elevated among young cancer survivors
Young cancer survivors were more than twice as likely to report loneliness at study baseline and follow-up.
News
FDA OKs elacestrant for ESR1+ advanced, metastatic breast cancer
The agency also approved the Guardant360 CDx assay as a companion diagnostic to identify breast cancer patients who meet the treatment...
From the Journals
Difficulty fitting family into career: Female oncologists
In a survey of female oncologists, 95% said their career plans were at least somewhat associated with the timing of when to start a family.
Feature
New cancer data spark outcry from patient advocates
The American Cancer Society on Jan. 13 revealed what it called ‘alarming’ news about prostate cancer.
From the Journals
Physician group issues 31 treatment recommendations for early-onset colorectal cancer
There was strong consensus that all individuals younger than 50 should undergo CRC risk stratification and prompt symptom assessment.
Conference Coverage
New ‘reference regimen’ in metastatic pancreatic cancer?
NALIRIFOX regimen can be considered new reference regimen for first-line pancreatic cancer treatment, a researcher reports at ASCO GI.
Conference Coverage
SUNLIGHT shows new standard of care in refractory metastatic CRC
Adding bevacizumab to trifluridine/tipiracil significantly improved survival, researchers report at ASCO GI.
Conference Coverage
Adding SBRT to sorafenib boosts survival in liver cancer
The use of SBRT in this setting improved both overall survival and progression-free survival, researchers reported at ASCO GI.
Conference Coverage
Regorafenib: New option for advanced gastroesophageal cancer?
Regorafenib significantly improves survival, compared with placebo, in patients with refractory AGOC, researchers report at ASCO GI.
Latest News
How should PRAME be used to evaluate melanocytic lesions?
One potential pitfall is that sun-damaged melanocytes may express PRAME.